Biotronik creates new online tool that identifies cardiac devices safe for MRI

Berlin-based Biotronik has created an online tool that advises physicians on the appropriate MR-conditional heart monitor or pacing or ICD system for patients.

Branded the ProMRI Configurator, the tool is an intuitive and user-friendly system that allows physicians to select desired MRI conditions and cardiac devices that are approved and available in their country, Biotronik said in a statement. By advising physicians on the best devices available, the configurator helps patients receive better care.

The system enables patients with a pacemaker, implantable defibrillator, cardiac monitor or cardiac resynchronization therapy defibrillator to undergo an MRI scan.

It’s the second offering from the ProMRI Check family. The first is the ProMRI SystemCheck, which allows physicians and patients to check whether an implanted cardiac system is MR-conditional.

“At Biotronik, we are deeply invested in enabling as many patients as possible to have access to MRI scans,” said Manuel Ortega, senior vice president at Biotronik, in a statement. “With the addition of the ProMRI Configurator to our portfolio, we are making further advances towards this goal by making it simpler for doctors to determine the best system for each patient.”

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.